Pregnancy and the mechanical prosthetic valve: Dilemmas around choice of antithrombotic prophylaxis;Zwangerschap en mechanische kunstklep: Dilemma's bij de keuze van antitrombotische profylaxe

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 7, 2007, Pages 389-394

  Roos Hesselink, J W ^a   Meijboom, F J ^a   Leebeek, F W G ^a   De Groot, C J M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AMENORRHEA; ARTICLE; CASE REPORT; DYSPNEA; FEMALE; FETAL HEMORRHAGE; HEART INFARCTION; HEART VALVE PROSTHESIS; HEART VENTRICLE THROMBOSIS; HOSPITAL DISCHARGE; HUMAN; PATIENT COUNSELING; PREGNANCY; PREGNANT WOMAN; TERATOGENICITY;

ADMINISTRATION, ORAL; ADULT; ANTICOAGULANTS; FEMALE; HEART VALVE PROSTHESIS; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RISK FACTORS; THROMBOEMBOLISM;

EID: 33847345085     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Schutte JM, Boer K de, Briët JW, Pel M, Santema JG, Schuitemaker NWE, et al. Moedersterfte in Nederland: het topje van de ijsberg. Nederlands Tijdschrift voor Obstetrie en Gynaecologie. 2005;118:89-91.
2. Martinez-Reding J, Cordero A, Kuri J, Martinez-Rios MA, Salazar E. Treatment of severe mitral stenosis with percutaneous balloon valvotomy in pregnant patients. Clin Cardiol. 1998;21:659-63.
3. Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol. 2005;46:403-10.
4. Elkayam UR. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. J Am Coll Cardiol. 1996;27:1704-6.
5. Steegers EAP, Thomas CMG, Boo TM de, Knapen MFCM, Merkus JMWM. Klinisch-chemische referentiewaarden in de zwangerschap. Maarssen: Elsevier; 1999.
6. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000;160:191-6.
7. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J. 1994;71:196-201.
8. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol. 1996;27:1698-703.
9. Vitale N, de Feo M, de Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33:1637-41.
10. De Santo LS, Romano G, della Corte A, Tizzano F, Petraio A, Amarelli C, et al. Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year follow-up. J Thorac Cardiovasc Surg. 2005;130:13-9.
11. Hanania G, Thomas D, Michel PL, Garbarz E, Age C, Millaire A, et al. Pregnancy and prosthetic heart valves: a French cooperative retrospective study of 155 cases. Eur Heart J. 1994;15:1651-8.
12. Sarig G, Brenner B. Monitoring of low molecular weight heparin (LMWH) in pregnancy. Thromb Res. 2005;115(Suppl 1):84-6.
13. Seshadri N, Goldhaber SZ, Elkayam U, Grimm RA, Groce 3rd JB, Heit JA, et al. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J. 2005;150:27-34.
14. Roberts N, Ross D, Flint SK, Arya R, Blott M. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin. BJOG. 2001;108:327-9.
15. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):627S-44S.
16. Butchart EG, Gohlke-Bärwolf C, Antunes MJ, Tornos P, de Caterina R, Cormier B, et al. Recommendations for the management of patients after heart valve surgery. Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Eur Heart J. 2005;26:2463-71.
17. Siu SC, Sermer M, Harrison DA, Grigoriadis E, Liu G, Sorensen S, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation. 1997;96:2789-94.
18. Roos-Hesselink JW, Kerstjens-Frederikse WS, Meijboom FJ, Pieper PG. Inheritance of congenital heart disease. Neth Heart J. 2005;13:88-91.